XTRA LIGHTENING COCKTAIL

5 Vials of 5 ml

Clarifying and withening solution with peptides 

XTRA Lightening works by reducing the synthesis of melanin, age spots and freckles. 

XTRA Lightening provides a clarifying, lightening, homogenizing and depigmenting effect on the skin, restoring vitality, brightness and transparency.

Using XTRA Lightening: 

• 8 to 12 mesotherapy sessions 

Arbutin: effectively inhibits the activity of tyrosinase and, therefore, the production of melanin. Arbutin acts following a binding competition mechanism in the active regions of the enzyme. 

In addition, arbutin has the ability to inhibit the DHICA product Polymerase (5,6-dihydroxyindole-2-carboxylic acid) resulting from the oxidation of tyrosine. 

Glycyrrhiza uralensis (licorice) root extract: inhibition of tyrosinase enzyme, and a slight action of reducing melanin precursors and color. Licorice extract also has anti-inflammatory properties by inhibiting superoxide anion synthesis and cyclooxygenase activity. Anti-aging effect to effectively absorb UVA and B. Anti-radical rays. 

3-O-ethyl Ascorbic acid: The depigmenting activity of ascorbic acid is due to both its tyrosinase inhibitory action and its ability to reduce dopaquinone to DOPA, which can also prevent the formation of melanin. 

Cromabright ™: inhibits tyrosinase activity. 

Significant depigmenting effect in melanocytes. It produces a powerful effect of skin whitening in vivo. photoprotective effect on cell cultures of keratinocytes of the human epidermis, acting as preventive ultraviolet-induced cutaneous lesions. 

Pentapeptide-13: With the clarification, the homogenizing properties of the skin complexion. Antioxidant 

Decapeptide-15: Clarification and whitening of the skin. Prevents photoaging Inhibits the synthesis of melanin by a mechanism of inhibition of tyrosinase expression. 

Oligopeptide-50: Inhibits the synthesis of melanin by inhibition of tyrosinase. Changes the morphology of melanocytes. Induces the reduction of melanin synthesis and the formation of melanosomes in melanocytes. Inhibits the expression of the melanogenesis marker. 

Oligopeptide-34: inhibits the synthesis of melanin. Reduces the activity of tyrosinase. It produces a decrease in melanosome formation in treated melanocytes. 

Oligopeptide-51 inhibits expression of the marker of melanogenesis. It inhibits the synthesis of melanin. Induces morphological changes in melanocytes. 

Glutathione: Glutathione has an SH reducing group. This functional group can form a complex with copper and reduce dopaquinone. Glutathione induces the formation of pheomelanin from dopaquinone